Cite
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk.
MLA
Bergmark, Brian A., et al. “Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk.” New England Journal of Medicine, vol. 390, no. 19, May 2024, pp. 1770–80. EBSCOhost, https://doi.org/10.1056/NEJMoa2402309.
APA
Bergmark, B. A., Marston, N. A., Prohaska, T. A., Alexander, V. J., Zimerman, A., Moura, F. A., Murphy, S. A., Goodrich, E. L., Shuanglu Zhang, Gaudet, D., Karwatowska-Prokopczuk, E., Tsimikas, S., Giugliano, R. P., & Sabatine, M. S. (2024). Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk. New England Journal of Medicine, 390(19), 1770–1780. https://doi.org/10.1056/NEJMoa2402309
Chicago
Bergmark, Brian A., Nicholas A. Marston, Thomas A. Prohaska, Veronica J. Alexander, André Zimerman, Filipe A. Moura, Sabina A. Murphy, et al. 2024. “Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk.” New England Journal of Medicine 390 (19): 1770–80. doi:10.1056/NEJMoa2402309.